Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
STRR | US
-0.35
-3.00%
Healthcare
Diagnostics & Research
30/06/2024
05/06/2026
11.30
11.65
11.65
10.09
Star Equity Holdings Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services Diagnostic Imaging Construction and Investments. It offers imaging services primarily to cardiologists internal medicine physicians and family practice doctors; and imaging systems including nuclear cardiac and general purpose nuclear imaging systems to physician offices and hospitals. The company also develops sells and maintains solid-state gamma cameras; and provides camera maintenance contract services. In addition it manufactures modular housing units structural wall panels permanent wood foundation systems and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings Inc. in December 2020. Star Equity Holdings Inc. was founded in 1985 and is headquartered in Old Greenwich Connecticut.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Weakness based on declining price with high volume
Price Below SMA10D
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
30.6%1 month
40.3%3 months
40.4%6 months
35.9%-
13.93
0.32
0.27
0.19
-5.32
0.87
-
-6.48M
36.40M
36.40M
-
-27.54
-21.60
51.60
-10.47
3.72
1.60
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.82
Range1M
2.90
Range3M
2.96
Rel. volume
1.70
Price X volume
141.44K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CCLD | CCLD | Health Information Services | 2.35 | 39.75M | -2.08% | n/a | 20.40% |
| Neuronetics Inc | STIM | Diagnostics & Research | 1.29 | 39.09M | -11.64% | n/a | 323.03% |
| Aclarion Inc | ACON | Health Information Services | 3.57 | 35.86M | 1.13% | n/a | 47.32% |
| Biomerica Inc | BMRA | Diagnostics & Research | 2.12 | 35.66M | -1.17% | n/a | 13.22% |
| Precipio Inc | PRPO | Diagnostics & Research | 23.49 | 34.82M | 0.56% | n/a | 9.66% |
| MDxHealth SA | MDXH | Diagnostics & Research | 0.5659 | 26.76M | -5.68% | n/a | -643.01% |
| Cytosorbents Corporation | CTSO | Diagnostics & Research | 0.459 | 24.98M | -5.94% | n/a | 159.92% |
| bioAffinity Technologies Inc. | BIAF | Diagnostics & Research | 1.73 | 23.34M | -7.98% | n/a | 40.20% |
| BioTelemetry Inc | BEAT | Diagnostics & Research | 0.8389 | 22.28M | -7.36% | n/a | 0.00% |
| MYnd Analytics Inc | MYND | Diagnostics & Research | 0.4003 | 18.27M | -11.24% | n/a | 117.50% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Reading International Inc | RDI | Media - Diversified | 1.18 | 33.31M | 0.85% | n/a | 4054.78% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 14.90M | -4.67% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.428 | 8.27M | 2.39% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.32 | 3.37M | -13.16% | n/a | 17.32% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.3876 | 213.57K | -7.71% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -5.32 | 12.67 | Cheaper |
| Ent. to Revenue | 0.87 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.32 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 40.38 | 59.59 | Lower Risk |
| Debt to Equity | 0.27 | -14.36 | Expensive |
| Debt to Assets | 0.19 | 0.34 | Cheaper |
| Market Cap | 36.40M | 13.71B | Emerging |